Merck Sharp + Dohme Corp.

Eric Dean Cline

Lihu Yang

Changyou Zhou

Haifeng Tang

Songnian Lin

Min Ge

Sunita Malkani

Bicyclic compounds containing a phenyl or pyridyl ring fused to a cycloalkyl or heterocyclic ring, to which is attached a 5-membered heterocyclic ring, including pharmaceutically acceptable salts and prodrugs thereof, are agonists of G-protein coupled receptor 40 (GPR40) and are useful as therapeutic compounds, particularly in the treatment of Type 2 diabetes mellitus, and of conditions that are often associated with this disease, including obesity and lipid disorders, such as mixed or diabetic dyslipidemia, hyperlipidemia, hypercholesterolemia, and hypertriglyceridemia.

Growing community of inventors

Princeton, NJ, United States of America

Eric Dean Cline